24/10/2026 00:07
|
Medical, Health & Aged Care
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery
Poster 1023P – Developmental Therapeutics
MADRID--BUSINESS WIRE--
Brenus...